Does CHA2DS2-VASc score predict mortality in chronic kidney disease?

Area of Science:

• Nephrology
• Cardiology
• Epidemiology

Background:

• Chronic kidney disease (CKD) is a major global health concern, significantly increasing morbidity and mortality.
• Assessing cardiovascular (CV) and all-cause mortality is crucial for managing CKD patients.
• The CHA2DS2-VASc score, initially for atrial fibrillation thromboembolism, is being explored for CKD risk stratification.

Purpose of the Study:

• To evaluate the utility of the CHA2DS2-VASc score in predicting CV and all-cause mortality in patients with CKD.
• To determine if modified scores (R2CHADS2, R2CHA2DS2VASc) offer improved risk prediction in CKD.

Main Methods:

• Analysis of existing studies investigating the CHA2DS2-VASc and R2CHADS±VASC scores in CKD populations.
• Review of literature assessing the correlation between these scores and mortality outcomes.

Main Results:

• The CHA2DS2-VASc score demonstrated significant predictive value for both CV and all-cause mortality in CKD patients.
• A positive correlation was observed between higher CHA2DS2-VASc scores and increased mortality rates.
• Modified scores incorporating renal function (R2CHADS2, R2CHA2DS2VASc) were also examined for their predictive capabilities.

Conclusions:

• The CHA2DS2-VASc score is a valuable tool for identifying CKD patients at higher risk of mortality.
• These findings support the use of the CHA2DS2-VASc score in clinical practice to guide risk assessment and management strategies in CKD.
• Further research may refine risk prediction models for CKD patients using enhanced scoring systems.